Androgenetic Alopecia, commonly known as male or female pattern baldness, is a genetic condition that affects a significant portion of the population. This type of hair loss is caused by a sensitivity to dihydrotestosterone (DHT), a hormone that affects hair follicles, leading to their gradual shrinking and eventual cessation of hair production.

In men, androgenetic alopecia often presents as a receding hairline and thinning at the crown, eventually progressing to partial or complete baldness. In women, the condition typically causes diffuse thinning across the scalp without a receding hairline, leading to a decrease in overall hair density.

Treatment options include medications such as minoxidil and finasteride, which can slow the progression of hair loss and promote regrowth in some cases. Surgical interventions like hair transplantation offer permanent solutions for restoring hair in affected areas.

Early diagnosis and intervention are key to managing androgenetic alopecia effectively. Patients benefit from personalized treatment plans tailored to their specific pattern and severity of hair loss, ensuring the best possible outcomes and improved confidence.